Back to today’s briefing

Story perspectives

Gene-Edited Cells Offer Hope for Type 1 Diabetes Cure

8/8/2025

31 3

Summary

Story summary

A groundbreaking study in the New England Journal of Medicine shows that gene-edited pancreatic cells may enable a man with type 1 diabetes to produce insulin without the need for immunosuppressants. Conducted by researchers in Sweden and the U.S., this promising proof-of-concept could pave the way for a revolutionary cure, overcoming the challenge of immune rejection in cell transplants.

1 of 1

Story summary

A groundbreaking study in the New England Journal of Medicine shows that gene-edited pancreatic cells may enable a man with type 1 diabetes to produce insulin without the need for immunosuppressants. Conducted by researchers in Sweden and the U.S., this promising proof-of-concept could pave the way for a revolutionary cure, overcoming the challenge of immune rejection in cell transplants.